CPR agrees with bipartisan, former top PTO officials that this must be immediately withdrawn. (If there’s room, include: Its far-reaching lengths are contrary to statute.)

History shows that price controls never achieve their stated ends and the IRA’s price controls are further evidence.

PTO's PTAB reforms won't restore balance to the patent system. It should codify Fintiv and require PTAB to accept a court’s or USITC’s decision that a patent is valid.

Qualifying innovations for FTC examination or enforcement would discourage developing drugs for indications with unmet medical needs, including cancers.

Bayh-Dole protects innovation and allows it to flourish, without the possibility of government expropriation of IP. March-in is not intended as a price control mechanism.

The IRA's 95% excise tax on medicines will be punitive, unworkable, and ultimately indefensible.

Marcum's new study of patent litigation shows that civil litigation now holds less promise of delivering justice to inventors and patent owners.

H.R. 3535 adds hurdles to the U.S. International Trade Commission’s ability to keep IP-infringing products out, enabling infringers to keep supply chains in China.

The Republican Study Committee budget for FY25 addresses several of CPR’s priorities. RSC halts federal land grabs. It repeals Obama-Biden WOTUS regulatory takings. It kills the Death Tax.

The Restoring America’s Leadership in Innovation Act would strengthen private intellectual property rights. RALIA would reverse the antipatent onslaught of recent years.

CPR commends the Countering Communist China Act for protecting property rights and increasing our vigilance, shoring up economic and national security against malign actors.

The Sunset Act reins in the Administrative State's rules, regulations, and guidance. They would no longer remain in force in perpetuity.

These excerpt public comments that oppose the Biden draft guidance for Bayh-Dole march-in to forcibly relicense patents if an agency disagrees with the product price.

The proposed guidance would endanger American economic competitiveness, inhibit innovation, impede public private partnerships, and harm U.S. technological leadership in cutting-edge sectors.

NIST proposes the most destructive policy: Injecting pricing into Bayh-Dole march-in, which has never been used and lacks statutory grounds for product price. NIST must withdraw it.

CPR commends Reps. Randy Feenstra (R-IA) and Sanford Bishop (D-GA) on the House Death Tax Repeal Act. It has over 160 original cosponsors, and the supporting coalition letter has nearly 160 signers.

WIPO seeks to impose new burdens on inventors. It breaks with decades of precedent, causes legal uncertainties, and undermines innovation.

Congress should encourage more investment in the American economy, including bonus depreciation, R&D deductions and EBITDA depreciation.

H.R. 6758 enables property owners to hold the federal government accountable for takings. Its more efficient, uniform process secures Fifth Amendment rights.